Gene · 79577
CDC73: cell division cycle 73
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CDC73: cell division cycle 73. Genes, record 79577. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/79577
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q6P1J9 | Parafibromin | 531 | 20 | Ensembl, GeneID, HGNC |
Source UniProt
Patents26
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 8231 | Q6P1J9 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 8400 | Q6P1J9 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 8400 | Q6P1J9 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8231 | Q6P1J9 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 5535 | Q6P1J9 | Espacenet |
| JP 2023106701 A | 2023-08-02 | 15 | Q6P1J9 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 13762 | Q6P1J9 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 116733 | Q6P1J9 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 1889 | Q6P1J9 | Espacenet |
| WO 2020043864 A1 | 2020-03-05 | 415 | Q6P1J9 | Espacenet |
1 to 10 of 26
See all 26 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants845
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CDC73 papers | Newest fiscal year |
|---|---|---|---|
| ZIADK043012 | Clinical Investigation of FIHP, Parathyroid Cancer & the HPT-JT Syndrome | 20 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 12 | 2025 |
| ZIADK043006 | Hyperparathyroidism -- Etiology, Diagnosis and Treatment | 12 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| U10CA180886 | COG NCTN Network Group Operations Center - Year 11 STAR Act MCI and PEC Supplement | 4 | 2025 |
| U10CA180899 | Children's Oncology Group Statistics and Data Center | 4 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 4 | 2025 |
| ZIADK075035 | Genes associated with endocrine tumorigenesis | 4 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 3 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 845Source NIH's project files
See all 845 nih grantsPapers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential tyrosine phosphorylation status of the nuclear scaffold Parafibromin/CDC73 determines its role in cancer development. | Biochem Biophys Res Commun | 2026 | 42772177 | PubTator, text mining | PubMed |
| JNK acts as a molecular brake of the CDC73 positive feedback loop to modulate osteosarcoma malignant progression via UBR5. | Oncogene | 2026 | 42749759 | PubTator, text mining | PubMed |
| Parathyroid carcinoma: epidemiology and genetics. | Endocr Oncol | 2026 | 42694707 | PubTator, text mining | PubMed |
| Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor. | J Visc Surg | 2026 | 42580893 | PubTator, text mining | PubMed |
| Critical Insights into Parathyroid Cancer. | J Cancer Sci Clin Ther | 2026 | 42577903 | PubTator, text mining | PubMed |
| Para This, Fibromin That: The Role of CDC73 in Parathyroid Tumors and Familial Tumor Syndromes. | Clin Lab Med | 2026 | 42526972 | PubTator, text mining | PubMed |
| Determination of the most suitable reference gene for transcription analysis of synovial tissue from osteoarthritis patients. | Sci Rep | 2026 | 42469336 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling and tumor mutational burden in parathyroid carcinoma: a nationwide real-world study from Japan. | Endocrine | 2026 | 42455276 | PubTator, text mining | PubMed |
| A case of CDC73 mutation-related primary hyperparathyroidism with ectopic parathyroid hyperplasia. | Proc (Bayl Univ Med Cent) | 2026 | 42454765 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics define a progenitor subpopulation and fibroinflammatory niche at the leading edge of parathyroid carcinoma. | Endocr Relat Cancer | 2026 | 42454544 | PubTator, text mining | PubMed |
1 to 10 of 1,751
See all 1,751 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/79577
GET https://conductscience.org/api/genes/v1/79577/patents?page=2